Form 4: Cyanotech Corp: CEO Matthew Custer Reports Stock Transactions

Sentiment:

SEC Form 4 Filing


President and CEO of Cyanotech Corp, Matthew Keith Custer, reports the conversion of restricted stock units into common stock.

Summary

  • On April 7, 2025, Matthew Keith Custer, President and CEO of Cyanotech Corp, converted 33 restricted stock units into common stock at a price of $0.
  • Following the transaction, Custer directly owns 4,679 shares of common stock.
  • Custer also directly owns 2,109 restricted stock units.
  • 2,075 restricted stock units vest on July 29, 2025, and 34 shares vest on April 6, 2026, contingent upon continued service with the company.

Sentiment

Score: 5

Explanation: The document is a neutral regulatory filing, reporting insider transactions. It doesn't inherently convey positive or negative sentiment.

Industry Context

This filing is a routine disclosure of insider transactions, which are common in publicly traded companies. It provides transparency into the actions of company executives regarding their holdings of company stock.

Stakeholder Impact

  • The transaction has a minor impact on shareholders as it reflects the CEO's compensation and ownership stake in the company.

Key Dates

DateDescription
04/07/2025Conversion of restricted stock units into common stock.
04/09/2025Date of signature by Power of Attorney.
07/29/2025Vesting date for 2,075 restricted stock units.
04/06/2026Vesting date for 34 restricted stock units.

Keywords

Form 4, insider trading, restricted stock units, stock conversion, Matthew Keith Custer, Cyanotech Corp, CYAN, CEO

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.